{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:35:51Z","timestamp":1774312551842,"version":"3.50.1"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,20]]},"DOI":"10.7759\/cureus.62788","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T02:02:26Z","timestamp":1718935346000},"source":"Crossref","is-referenced-by-count":2,"title":["Understanding the Interplay Between Premenstrual Dysphoric Disorder (PMDD) and Female Sexual Dysfunction (FSD)"],"prefix":"10.7759","author":[{"given":"Mahati","family":"Gollapudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelina","family":"Yogarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ospina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean C","family":"Daher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaliya","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Santistevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruby V","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeby","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheethal G","family":"Oommen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humza F","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.vh.2018.01.016","article-title":"The menstrual cycle influences emotion but has limited effect on cognitive function","volume":"107","author":"Sundstr\u00f6m-Poromaa I","year":"2018","unstructured":"Sundstr\u00f6m-Poromaa I. The menstrual cycle influences emotion but has limited effect on cognitive function. Vitam Horm. 2018, 107:349-376. 10.1016\/bs.vh.2018.01.016","journal-title":"Vitam Horm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jog.15484","article-title":"Premenstrual disorders: premenstrual syndrome and premenstrual dysphoric disorder","volume":"49","author":"Takeda T","year":"2023","unstructured":"Takeda T. Premenstrual disorders: premenstrual syndrome and premenstrual dysphoric disorder. J Obstet Gynaecol Res. 2023, 49:510-518. 10.1111\/jog.15484","journal-title":"J Obstet Gynaecol Res"},{"key":"ref3","article-title":"Sex steroid-related candidate genes in psychiatric disorders","volume":"33","author":"Westberg L","year":"2008","unstructured":"Westberg L, Eriksson E. Sex steroid-related candidate genes in psychiatric disorders. J Psychiatry Neurosci. 2008, 33:319-330.","journal-title":"J Psychiatry Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1258\/mi.2012.012014","article-title":"Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder","volume":"18","author":"Rapkin AJ","year":"2012","unstructured":"Rapkin AJ, Akopians AL. Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder. Menopause Int. 2012, 18:52-59. 10.1258\/mi.2012.012014","journal-title":"Menopause Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2019.02.007","article-title":"Premenstrual dysphoric disorder","volume":"103","author":"Lanza di Scalea T","year":"2019","unstructured":"Lanza di Scalea T, Pearlstein T. Premenstrual dysphoric disorder. Med Clin North Am. 2019, 103:613-628. 10.1016\/j.mcna.2019.02.007","journal-title":"Med Clin North Am"},{"key":"ref6","article-title":"Premenstrual dysphoric disorder: burden of illness and treatment update","volume":"33","author":"Pearlstein T","year":"2008","unstructured":"Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci. 2008, 33:291-301.","journal-title":"J Psychiatry Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2018.1534097","article-title":"Changes in premenstrual symptoms in women starting or discontinuing use of oral contraceptives","volume":"35","author":"Ekenros L","year":"2019","unstructured":"Ekenros L, B\u00e4ckstr\u00f6m T, Hirschberg AL, Frid\u00e9n C. Changes in premenstrual symptoms in women starting or discontinuing use of oral contraceptives. Gynecol Endocrinol. 2019, 35:422-426. 10.1080\/09513590.2018.1534097","journal-title":"Gynecol Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13030-022-00240-7","article-title":"Roles of childhood maltreatment, personality traits, and life stress in the prediction of severe premenstrual symptoms","volume":"16","author":"Morishita C","year":"2022","unstructured":"Morishita C, Inoue T, Honyashiki M, et al.. Roles of childhood maltreatment, personality traits, and life stress in the prediction of severe premenstrual symptoms. Biopsychosoc Med. 2022, 16:11. 10.1186\/s13030-022-00240-7","journal-title":"Biopsychosoc Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-015-0628-3","article-title":"Premenstrual dysphoric disorder: epidemiology and treatment","volume":"17","author":"Hantsoo L","year":"2015","unstructured":"Hantsoo L, Epperson CN. Premenstrual dysphoric disorder: epidemiology and treatment. Curr Psychiatry Rep. 2015, 17:87. 10.1007\/s11920-015-0628-3","journal-title":"Curr Psychiatry Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291701004925","article-title":"Prevalence, incidence and stability of premenstrual dysphoric disorder in the community","volume":"32","author":"Wittchen H -U","year":"2002","unstructured":"Wittchen H -U, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002, 32:119-132. 10.1017\/s0033291701004925","journal-title":"Psychol Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12529-016-9564-9","article-title":"Psychosocial profile of women with premenstrual syndrome and healthy controls: a comparative study","volume":"23","author":"Kleinst\u00e4uber M","year":"2016","unstructured":"Kleinst\u00e4uber M, Schmelzer K, Ditzen B, Andersson G, Hiller W, Weise C. Psychosocial profile of women with premenstrual syndrome and healthy controls: a comparative study. Int J Behav Med. 2016, 23:752-763. 10.1007\/s12529-016-9564-9","journal-title":"Int J Behav Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-016-0634-4","article-title":"Emotion regulation in women with premenstrual dysphoric disorder","volume":"19","author":"Petersen N","year":"2016","unstructured":"Petersen N, London ED, Liang L, Ghahremani DG, Gerards R, Goldman L, Rapkin AJ. Emotion regulation in women with premenstrual dysphoric disorder. Arch Womens Ment Health. 2016, 19:891-898. 10.1007\/s00737-016-0634-4","journal-title":"Arch Womens Ment Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291717003270","article-title":"Brain activation during emotion regulation in women with premenstrual dysphoric disorder","volume":"48","author":"Petersen N","year":"2018","unstructured":"Petersen N, Ghahremani DG, Rapkin AJ, Berman SM, Liang L, London ED. Brain activation during emotion regulation in women with premenstrual dysphoric disorder. Psychol Med. 2018, 48:1795-1802. 10.1017\/S0033291717003270","journal-title":"Psychol Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/sxmrev\/qead007","article-title":"Premenstrual dysphoric disorder and sexual function: a narrative review","volume":"11","author":"Susser LC","year":"2023","unstructured":"Susser LC, Parish S, Dumas E, Nappi RE. Premenstrual dysphoric disorder and sexual function: a narrative review. Sex Med Rev. 2023, 11:202-211. 10.1093\/sxmrev\/qead007","journal-title":"Sex Med Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-4530(03)00098-2","article-title":"The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS\/PMDD)","volume":"28","author":"Halbreich U","year":"2003","unstructured":"Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS\/PMDD). Psychoneuroendocrinology. 2003, 28:1-23. 10.1016\/s0306-4530(03)00098-2","journal-title":"Psychoneuroendocrinology"},{"key":"ref16","article-title":"Premenstrual syndrome and premenstrual dysphoric disorder","volume":"84","author":"Biggs WS","year":"2011","unstructured":"Biggs WS, Demuth RH. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician. 2011, 84:918-924.","journal-title":"Am Fam Physician"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/01.JAA.0000923584.68461.f2","article-title":"Premenstrual dysphoric disorder","volume":"36","author":"Strelow B","year":"2023","unstructured":"Strelow B. Premenstrual dysphoric disorder. JAAPA. 2023, 36:45-46. 10.1097\/01.JAA.0000923584.68461.f2","journal-title":"JAAPA"},{"key":"ref18","article-title":"Premenstrual syndrome and premenstrual dysphoric disorder","volume":"94","author":"Hofmeister S","year":"2016","unstructured":"Hofmeister S, Bodden S. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician. 2016, 94:236-240.","journal-title":"Am Fam Physician"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000339","article-title":"Premenstrual syndrome: evidence-based evaluation and treatment","volume":"61","author":"Appleton SM","year":"2018","unstructured":"Appleton SM. Premenstrual syndrome: evidence-based evaluation and treatment. Clin Obstet Gynecol. 2018, 61:52-61. 10.1097\/GRF.0000000000000339","journal-title":"Clin Obstet Gynecol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0033294120979696","article-title":"Psychometric properties of a DSM-5-based screening tool for women's perceptions of premenstrual symptoms","volume":"125","author":"Richards MA","year":"2022","unstructured":"Richards MA, Oinonen KA. Psychometric properties of a DSM-5-based screening tool for women's perceptions of premenstrual symptoms. Psychol Rep. 2022, 125:1186-1217. 10.1177\/0033294120979696","journal-title":"Psychol Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cppeds.2022.101187","article-title":"Premenstrual syndrome and premenstrual dysphoric disorder in adolescents","volume":"52","author":"Itriyeva K","year":"2022","unstructured":"Itriyeva K. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents. Curr Probl Pediatr Adolesc Health Care. 2022, 52:101187. 10.1016\/j.cppeds.2022.101187","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2017.01.002","article-title":"Premenstrual dysphoric disorder","volume":"40","author":"Lanza di Scalea T","year":"2017","unstructured":"Lanza di Scalea T, Pearlstein T. Premenstrual dysphoric disorder. Psychiatr Clin North Am. 2017, 40:201-216. 10.1016\/j.psc.2017.01.002","journal-title":"Psychiatr Clin North Am"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2017.05.018","article-title":"Premenstrual dysphoric disorder: contemporary diagnosis and management","volume":"40","author":"Reid RL","year":"2018","unstructured":"Reid RL, Soares CN. Premenstrual dysphoric disorder: contemporary diagnosis and management. J Obstet Gynaecol Can. 2018, 40:215-223. 10.1016\/j.jogc.2017.05.018","journal-title":"J Obstet Gynaecol Can"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2015.08.010","article-title":"Premenstrual syndrome: a mini review","volume":"82","author":"Ryu A","year":"2015","unstructured":"Ryu A, Kim TH. Premenstrual syndrome: a mini review. Maturitas. 2015, 82:436-440. 10.1016\/j.maturitas.2015.08.010","journal-title":"Maturitas"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-021-03567-7","article-title":"Premenstrual dysphoric disorder and childhood maltreatment, adulthood stressful life events and depression among Lebanese university students: a structural equation modeling approach","volume":"21","author":"Younes Y","year":"2021","unstructured":"Younes Y, Hallit S, Obeid S. Premenstrual dysphoric disorder and childhood maltreatment, adulthood stressful life events and depression among Lebanese university students: a structural equation modeling approach. BMC Psychiatry. 2021, 21:548. 10.1186\/s12888-021-03567-7","journal-title":"BMC Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsycho.2004.08.002","article-title":"Histories of sexual abuse are associated with differential effects of clonidine on autonomic function in women with premenstrual dysphoric disorder","volume":"69","author":"Bunevicius R","year":"2005","unstructured":"Bunevicius R, Hinderliter AL, Light KC, Leserman J, Pedersen CA, Girdler SS. Histories of sexual abuse are associated with differential effects of clonidine on autonomic function in women with premenstrual dysphoric disorder. Biol Psychol. 2005, 69:281-296. 10.1016\/j.biopsycho.2004.08.002","journal-title":"Biol Psychol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1089\/15246090050147736","article-title":"Premenstrual symptom severity: impact on social functioning and treatment-seeking behaviors","volume":"9","author":"Robinson RL","year":"2000","unstructured":"Robinson RL, Swindle RW. Premenstrual symptom severity: impact on social functioning and treatment-seeking behaviors. J Womens Health Gend Based Med. 2000, 9:757-768. 10.1089\/15246090050147736","journal-title":"J Womens Health Gend Based Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2006.10.007","article-title":"Premenstrual syndrome and premenstrual dysphoric disorder","volume":"20","author":"Braverman PK","year":"2007","unstructured":"Braverman PK. Premenstrual syndrome and premenstrual dysphoric disorder. J Pediatr Adolesc Gynecol. 2007, 20:3-12. 10.1016\/j.jpag.2006.10.007","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"ref29","article-title":"Premenstrual dysphoric disorder--review of actual findings about mental disorders related to menstrual cycle and possibilities of their therapy","volume":"111","author":"Zukov I","year":"2010","unstructured":"Zukov I, Pt\u00e1cek R, Raboch J, Domluvilov\u00e1 D, Kuzelov\u00e1 H, Fischer S, Kozelek P. Premenstrual dysphoric disorder--review of actual findings about mental disorders related to menstrual cycle and possibilities of their therapy. Prague Med Rep. 2010, 111:12-24.","journal-title":"Prague Med Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-020-01100-8","article-title":"Women's experiences of receiving a diagnosis of premenstrual dysphoric disorder: a qualitative investigation","volume":"20","author":"Osborn E","year":"2020","unstructured":"Osborn E, Wittkowski A, Brooks J, Briggs PE, O'Brien PM. Women's experiences of receiving a diagnosis of premenstrual dysphoric disorder: a qualitative investigation. BMC Womens Health. 2020, 20:242. 10.1186\/s12905-020-01100-8","journal-title":"BMC Womens Health"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-10-1","article-title":"Health related quality of life among adolescents with premenstrual disorders: a cross sectional study","volume":"10","author":"Delara M","year":"2012","unstructured":"Delara M, Ghofranipour F, Azadfallah P, Tavafian SS, Kazemnejad A, Montazeri A. Health related quality of life among adolescents with premenstrual disorders: a cross sectional study. Health Qual Life Outcomes. 2012, 10:1. 10.1186\/1477-7525-10-1","journal-title":"Health Qual Life Outcomes"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4103\/ipj.ipj_79_19","article-title":"Prevalence of premenstrual dysphoric disorder among school-going adolescent girls","volume":"28","author":"Gupta M","year":"2019","unstructured":"Gupta M, Dua D, Kaur H, Grover S. Prevalence of premenstrual dysphoric disorder among school-going adolescent girls. Ind Psychiatry J. 2019, 28:198-202. 10.4103\/ipj.ipj_79_19","journal-title":"Ind Psychiatry J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4103\/0972-6748.181718","article-title":"Premenstrual dysphoric disorder in medical students residing in hostel and its association with lifestyle factors","volume":"24","author":"Mishra A","year":"2015","unstructured":"Mishra A, Banwari G, Yadav P. Premenstrual dysphoric disorder in medical students residing in hostel and its association with lifestyle factors. Ind Psychiatry J. 2015, 24:150-157. 10.4103\/0972-6748.181718","journal-title":"Ind Psychiatry J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0327(01)00458-x","article-title":"Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles","volume":"70","author":"Cohen LS","year":"2002","unstructured":"Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Affect Disord. 2002, 70:125-132. 10.1016\/s0165-0327(01)00458-x","journal-title":"J Affect Disord"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.gaceta.2021.10.103","article-title":"The effect of estrogen hormone on premenstrual syndrome (PMS) occurrences in teenage girls at Pesantren Darul Arqam Makassar","volume":"35 Suppl 2","author":"Noviyanti NI","year":"2021","unstructured":"Noviyanti NI, Gusriani, Ruqaiyah, Mappaware NA, Ahmad M. The effect of estrogen hormone on premenstrual syndrome (PMS) occurrences in teenage girls at Pesantren Darul Arqam Makassar. Gac Sanit. 2021, 35 Suppl 2:S571-S575. 10.1016\/j.gaceta.2021.10.103","journal-title":"Gac Sanit"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.107136","article-title":"Hormonal and volume dysregulation in women with premenstrual syndrome","volume":"51","author":"Rosenfeld R","year":"2008","unstructured":"Rosenfeld R, Livne D, Nevo O, Dayan L, Milloul V, Lavi S, Jacob G. Hormonal and volume dysregulation in women with premenstrual syndrome. Hypertension. 2008, 51:1225-1230. 10.1161\/HYPERTENSIONAHA.107.107136","journal-title":"Hypertension"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16224352","article-title":"Early- and late-luteal-phase estrogen and progesterone levels of women with premenstrual dysphoric disorder","volume":"16","author":"Yen JY","year":"2019","unstructured":"Yen JY, Lin HC, Lin PC, Liu TL, Long CY, Ko CH. Early- and late-luteal-phase estrogen and progesterone levels of women with premenstrual dysphoric disorder. Int J Environ Res Public Health. 2019, 16:4352. 10.3390\/ijerph16224352","journal-title":"Int J Environ Res Public Health"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa309","article-title":"Pubertal development and risk of premenstrual disorders in young adulthood","volume":"36","author":"Lu D","year":"2021","unstructured":"Lu D, Aleknaviciute J, Bjarnason R, Tamimi RM, Valdimarsd\u00f3ttir UA, Bertone-Johnson ER. Pubertal development and risk of premenstrual disorders in young adulthood. Hum Reprod. 2021, 36:455-464. 10.1093\/humrep\/deaa309","journal-title":"Hum Reprod"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291700036205","article-title":"Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms","volume":"25","author":"Freeman EW","year":"1995","unstructured":"Freeman EW, Rickels K, Schweizer E, Ting T. Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms. Psychol Med. 1995, 25:309-315. 10.1017\/s0033291700036205","journal-title":"Psychol Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-013-0018-4","article-title":"Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents","volume":"15","author":"Rapkin AJ","year":"2013","unstructured":"Rapkin AJ, Mikacich JA. Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents. Paediatr Drugs. 2013, 15:191-202. 10.1007\/s40272-013-0018-4","journal-title":"Paediatr Drugs"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1177\/1745506518762664","article-title":"Women's sexual dysfunction associated with psychiatric disorders and their treatment","volume":"14","author":"Basson R","year":"2018","unstructured":"Basson R, Gilks T. Women's sexual dysfunction associated with psychiatric disorders and their treatment. Womens Health (Lond). 2018, 14:1745506518762664. 10.1177\/1745506518762664","journal-title":"Womens Health (Lond)"},{"key":"ref42","article-title":"Sexual dysfunction in women: a practical approach","volume":"92","author":"Faubion SS","year":"2015","unstructured":"Faubion SS, Rullo JE. Sexual dysfunction in women: a practical approach. Am Fam Physician. 2015, 92:281-288.","journal-title":"Am Fam Physician"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2017.12.004","article-title":"Female sexual dysfunction: a systematic review of outcomes across various treatment modalities","volume":"7","author":"Weinberger JM","year":"2019","unstructured":"Weinberger JM, Houman J, Caron AT, Anger J. Female sexual dysfunction: a systematic review of outcomes across various treatment modalities. Sex Med Rev. 2019, 7:223-250. 10.1016\/j.sxmr.2017.12.004","journal-title":"Sex Med Rev"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003941","article-title":"Female sexual dysfunction: pharmacologic and therapeutic interventions","volume":"136","author":"Wheeler LJ","year":"2020","unstructured":"Wheeler LJ, Guntupalli SR. Female sexual dysfunction: pharmacologic and therapeutic interventions. Obstet Gynecol. 2020, 136:174-186. 10.1097\/AOG.0000000000003941","journal-title":"Obstet Gynecol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2019.02.008","article-title":"Female sexual dysfunction","volume":"103","author":"Clayton AH","year":"2019","unstructured":"Clayton AH, Valladares Juarez EM. Female sexual dysfunction. Med Clin North Am. 2019, 103:681-698. 10.1016\/j.mcna.2019.02.008","journal-title":"Med Clin North Am"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0288-1","article-title":"The female sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire disorder","volume":"29","author":"Kingsberg SA","year":"2015","unstructured":"Kingsberg SA, Clayton AH, Pfaus JG. The female sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire disorder. CNS Drugs. 2015, 29:915-933. 10.1007\/s40263-015-0288-1","journal-title":"CNS Drugs"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2016.09.020","article-title":"Toward a more evidence-based nosology and nomenclature for female sexual dysfunctions-part II","volume":"13","author":"Parish SJ","year":"2016","unstructured":"Parish SJ, Goldstein AT, Goldstein SW, et al.. Toward a more evidence-based nosology and nomenclature for female sexual dysfunctions-part II. J Sex Med. 2016, 13:1888-1906. 10.1016\/j.jsxm.2016.09.020","journal-title":"J Sex Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.4907","article-title":"A practical guide to female sexual dysfunction: an evidence-based review for physicians in Canada","volume":"12","author":"Krakowsky Y","year":"2018","unstructured":"Krakowsky Y, Grober ED. A practical guide to female sexual dysfunction: an evidence-based review for physicians in Canada. Can Urol Assoc J. 2018, 12:211-216. 10.5489\/cuaj.4907","journal-title":"Can Urol Assoc J"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2016.09.013","article-title":"Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL)","volume":"94","author":"Nappi RE","year":"2016","unstructured":"Nappi RE, Cucinella L, Martella S, Rossi M, Tiranini L, Martini E. Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL). Maturitas. 2016, 94:87-91. 10.1016\/j.maturitas.2016.09.013","journal-title":"Maturitas"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-021-01559-z","article-title":"Evaluation of sexual dysfunction in gynecologic cancer survivors using DSM-5 diagnostic criteria","volume":"22","author":"Lin H","year":"2022","unstructured":"Lin H, Fu HC, Wu CH, Tsai YJ, Chou YJ, Shih CM, Ou YC. Evaluation of sexual dysfunction in gynecologic cancer survivors using DSM-5 diagnostic criteria. BMC Womens Health. 2022, 22:1. 10.1186\/s12905-021-01559-z","journal-title":"BMC Womens Health"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12379","article-title":"A comparison of DSM-IV-TR and DSM-5 definitions for sexual dysfunctions: critiques and challenges","volume":"11","author":"Sungur MZ","year":"2014","unstructured":"Sungur MZ, G\u00fcnd\u00fcz A. A comparison of DSM-IV-TR and DSM-5 definitions for sexual dysfunctions: critiques and challenges. J Sex Med. 2014, 11:364-373. 10.1111\/jsm.12379","journal-title":"J Sex Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.01.009","article-title":"The International Society for the Study of Women's Sexual Health Process of Care for the Identification of Sexual Concerns and Problems in Women","volume":"94","author":"Parish SJ","year":"2019","unstructured":"Parish SJ, Hahn SR, Goldstein SW, et al.. The International Society for the Study of Women's Sexual Health Process of Care for the Identification of Sexual Concerns and Problems in Women. Mayo Clin Proc. 2019, 94:842-856. 10.1016\/j.mayocp.2019.01.009","journal-title":"Mayo Clin Proc"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2020.05.001","article-title":"The evolution of the female sexual disorder\/dysfunction definitions, nomenclature, and classifications: a review of DSM, ICSM, ISSWSH, and ICD","volume":"9","author":"Parish SJ","year":"2021","unstructured":"Parish SJ, Cottler-Casanova S, Clayton AH, McCabe MP, Coleman E, Reed GM. The evolution of the female sexual disorder\/dysfunction definitions, nomenclature, and classifications: a review of DSM, ICSM, ISSWSH, and ICD. Sex Med Rev. 2021, 9:36-56. 10.1016\/j.sxmr.2020.05.001","journal-title":"Sex Med Rev"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181898cdb","article-title":"Sexual problems and distress in United States women: prevalence and correlates","volume":"112","author":"Shifren JL","year":"2008","unstructured":"Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008, 112:970-978. 10.1097\/AOG.0b013e3181898cdb","journal-title":"Obstet Gynecol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.12968\/bjon.2021.30.18.S18","article-title":"Understanding female sexual dysfunction, its causes and treatments","volume":"30","author":"Gregory A","year":"2021","unstructured":"Gregory A. Understanding female sexual dysfunction, its causes and treatments. Br J Nurs. 2021, 30:S18-S29. 10.12968\/bjon.2021.30.18.S18","journal-title":"Br J Nurs"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.08.006","article-title":"Arriving at the diagnosis of female sexual dysfunction","volume":"100","author":"Latif EZ","year":"2013","unstructured":"Latif EZ, Diamond MP. Arriving at the diagnosis of female sexual dysfunction. Fertil Steril. 2013, 100:898-904. 10.1016\/j.fertnstert.2013.08.006","journal-title":"Fertil Steril"},{"key":"ref57","article-title":"Diagnosis and treatment of female sexual dysfunction","volume":"77","author":"Frank JE","year":"2008","unstructured":"Frank JE, Mistretta P, Will J. Diagnosis and treatment of female sexual dysfunction. Am Fam Physician. 2008, 77:635-642.","journal-title":"Am Fam Physician"},{"key":"ref58","article-title":"Female sexual dysfunction: evaluation and treatment","volume":"62","author":"Phillips NA","year":"2000","unstructured":"Phillips NA. Female sexual dysfunction: evaluation and treatment. Am Fam Physician. 2000, 62:127-136.","journal-title":"Am Fam Physician"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2013.01.002","article-title":"Female sexual dysfunction: definition, classification, and debates","volume":"52","author":"Chen CH","year":"2013","unstructured":"Chen CH, Lin YC, Chiu LH, Chu YH, Ruan FF, Liu WM, Wang PH. Female sexual dysfunction: definition, classification, and debates. Taiwan J Obstet Gynecol. 2013, 52:3-7. 10.1016\/j.tjog.2013.01.002","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.2174\/1381612827666210719104950","article-title":"Female sexual dysfunction: a problem hidden in the shadows","volume":"27","author":"Imprialos KP","year":"2021","unstructured":"Imprialos KP, Koutsampasopoulos K, Katsimardou A, Bouloukou S, Theodoulidis I, Themistoklis M, Doumas M. Female sexual dysfunction: a problem hidden in the shadows. Curr Pharm Des. 2021, 27:3762-3774. 10.2174\/1381612827666210719104950","journal-title":"Curr Pharm Des"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2010.06.010","article-title":"Female sexual dysfunction","volume":"153","author":"Jha S","year":"2010","unstructured":"Jha S, Thakar R. Female sexual dysfunction. Eur J Obstet Gynecol Reprod Biol. 2010, 153:117-123. 10.1016\/j.ejogrb.2010.06.010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2016.02.172","article-title":"The physiology of female sexual function and the pathophysiology of female sexual dysfunction (committee 13a)","volume":"13","author":"Levin RJ","year":"2016","unstructured":"Levin RJ, Both S, Georgiadis J, Kukkonen T, Park K, Yang CC. The physiology of female sexual function and the pathophysiology of female sexual dysfunction (committee 13a). J Sex Med. 2016, 13:733-759. 10.1016\/j.jsxm.2016.02.172","journal-title":"J Sex Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001427","article-title":"Female sexuality and vaginal health across the menopausal age","volume":"27","author":"Cagnacci A","year":"2020","unstructured":"Cagnacci A, Venier M, Xholli A, Paglietti C, Caruso S. Female sexuality and vaginal health across the menopausal age. Menopause. 2020, 27:14-19. 10.1097\/GME.0000000000001427","journal-title":"Menopause"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1097\/01.NPR.0000440641.32261.7c","article-title":"Pharmacologic therapy for female sexual dysfunction","volume":"39","author":"Bradway C","year":"2014","unstructured":"Bradway C, Boullata J. Pharmacologic therapy for female sexual dysfunction. Nurse Pract. 2014, 39:16-27. 10.1097\/01.NPR.0000440641.32261.7c","journal-title":"Nurse Pract"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1080\/0092623X.2017.1305030","article-title":"Premenstrual syndrome is associated with a higher frequency of female sexual difficulty and sexual distress","volume":"43","author":"\u0130lhan G","year":"2017","unstructured":"\u0130lhan G, Verit Atmaca FV, Kurek Eken M, Akyol H. Premenstrual syndrome is associated with a higher frequency of female sexual difficulty and sexual distress. J Sex Marital Ther. 2017, 43:811-821. 10.1080\/0092623X.2017.1305030","journal-title":"J Sex Marital Ther"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1080\/0092623X.2020.1856988","article-title":"Premenstrual syndrome and female sexual function","volume":"47","author":"Conzatti M","year":"2021","unstructured":"Conzatti M, Maciel RF, Perez AV, De Castro DH, Sbaraini M, Wender MC. Premenstrual syndrome and female sexual function. J Sex Marital Ther. 2021, 47:186-196. 10.1080\/0092623X.2020.1856988","journal-title":"J Sex Marital Ther"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828x.1979.tb01367.x","article-title":"Social and psychological factors in relation to premenstrual tension and menstrual pain","volume":"19","author":"Wood C","year":"1979","unstructured":"Wood C, Larsen L, Williams R. Social and psychological factors in relation to premenstrual tension and menstrual pain. Aust N Z J Obstet Gynaecol. 1979, 19:111-115. 10.1111\/j.1479-828x.1979.tb01367.x","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"ref68","doi-asserted-by":"crossref","DOI":"10.1097\/00006205-199105000-00006","article-title":"Dispelling myths: a study of PMS and relationship satisfaction","volume":"16","author":"Winter EJ","year":"1991","unstructured":"Winter EJ, Ashton DJ, Moore DL. Dispelling myths: a study of PMS and relationship satisfaction. Nurse Pract. 1991, 16:37-40.","journal-title":"Nurse Pract"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.01927.x","article-title":"Sexual satisfaction in females with premenstrual symptoms","volume":"7","author":"Nowosielski K","year":"2010","unstructured":"Nowosielski K, Drosdzol A, Skrzypulec V, Plinta R. Sexual satisfaction in females with premenstrual symptoms. J Sex Med. 2010, 7:3589-3597. 10.1111\/j.1743-6109.2010.01927.x","journal-title":"J Sex Med"},{"key":"ref70","article-title":"Interpreting Premenstrual Symptoms Impact Survey scores using outcomes in health-related quality of life and sexual drive impact","volume":"55","author":"Yang M","year":"2010","unstructured":"Yang M, Gricar JA, Maruish ME, Hagan MA, Kornstein SG, Wallenstein GV. Interpreting Premenstrual Symptoms Impact Survey scores using outcomes in health-related quality of life and sexual drive impact. J Reprod Med. 2010, 55:41-48.","journal-title":"J Reprod Med"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2016.01.019","article-title":"Psychological and interpersonal dimensions of sexual function and dysfunction","volume":"13","author":"Brotto L","year":"2016","unstructured":"Brotto L, Atallah S, Johnson-Agbakwu C, et al.. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med. 2016, 13:538-571. 10.1016\/j.jsxm.2016.01.019","journal-title":"J Sex Med"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001396.pub3","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome","volume":"2013","author":"Marjoribanks J","year":"2013","unstructured":"Marjoribanks J, Brown J, O'Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013, 2013:CD001396. 10.1002\/14651858.CD001396.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S83747","article-title":"Female sexual dysfunction: a focus on flibanserin","volume":"9","author":"Lodise NM","year":"2017","unstructured":"Lodise NM. Female sexual dysfunction: a focus on flibanserin. Int J Womens Health. 2017, 9:757-767. 10.2147\/IJWH.S83747","journal-title":"Int J Womens Health"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003500","article-title":"Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials","volume":"134","author":"Kingsberg SA","year":"2019","unstructured":"Kingsberg SA, Clayton AH, Portman D, et al.. Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials. Obstet Gynecol. 2019, 134:899-908. 10.1097\/AOG.0000000000003500","journal-title":"Obstet Gynecol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint14010006","article-title":"Bremelanotide for treatment of female hypoactive sexual desire","volume":"14","author":"Edinoff AN","year":"2022","unstructured":"Edinoff AN, Sanders NM, Lewis KB, Apgar TL, Cornett EM, Kaye AM, Kaye AD. Bremelanotide for treatment of female hypoactive sexual desire. Neurol Int. 2022, 14:75-88. 10.3390\/neurolint14010006","journal-title":"Neurol Int"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000985","article-title":"A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom","volume":"25","author":"Kroll R","year":"2018","unstructured":"Kroll R, Archer DF, Lin Y, Sniukiene V, Liu JH. A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom. Menopause. 2018, 25:133-138. 10.1097\/GME.0000000000000985","journal-title":"Menopause"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.12703\/r\/10-25","article-title":"Modern management of genitourinary syndrome of menopause","volume":"10","author":"Da Silva AS","year":"2021","unstructured":"Da Silva AS, Baines G, Araklitis G, Robinson D, Cardozo L. Modern management of genitourinary syndrome of menopause. Fac Rev. 2021, 10:25. 10.12703\/r\/10-25","journal-title":"Fac Rev"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.6118\/jmm.2017.23.2.79","article-title":"Ospemifene: a novel option for the treatment of vulvovaginal atrophy","volume":"23","author":"Shin JJ","year":"2017","unstructured":"Shin JJ, Kim SK, Lee JR, Suh CS. Ospemifene: a novel option for the treatment of vulvovaginal atrophy. J Menopausal Med. 2017, 23:79-84. 10.6118\/jmm.2017.23.2.79","journal-title":"J Menopausal Med"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2016.1142371","article-title":"Treatment of premenstrual dysphoric disorder: therapeutic challenges","volume":"9","author":"Pearlstein T","year":"2016","unstructured":"Pearlstein T. Treatment of premenstrual dysphoric disorder: therapeutic challenges. Expert Rev Clin Pharmacol. 2016, 9:493-496. 10.1586\/17512433.2016.1142371","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-023-01004-9","article-title":"New pharmacological approaches to the management of premenstrual dysphoric disorder","volume":"37","author":"Sundstr\u00f6m-Poromaa I","year":"2023","unstructured":"Sundstr\u00f6m-Poromaa I, Comasco E. New pharmacological approaches to the management of premenstrual dysphoric disorder. CNS Drugs. 2023, 37:371-379. 10.1007\/s40263-023-01004-9","journal-title":"CNS Drugs"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X20666220222145735","article-title":"The role of bupropion in the treatment of women with sexual desire disorder: a systematic review and meta-analysis","volume":"20","author":"Razali NA","year":"2022","unstructured":"Razali NA, Sidi H, Choy CL, Roos NA, Baharudin A, Das S. The role of bupropion in the treatment of women with sexual desire disorder: a systematic review and meta-analysis. Curr Neuropharmacol. 2022, 20:1941-1955. 10.2174\/1570159X20666220222145735","journal-title":"Curr Neuropharmacol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.2147\/OAJC.S183193","article-title":"Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives","volume":"10","author":"Rapkin AJ","year":"2019","unstructured":"Rapkin AJ, Korotkaya Y, Taylor KC. Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives. Open Access J Contracept. 2019, 10:27-39. 10.2147\/OAJC.S183193","journal-title":"Open Access J Contracept"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2015.11.003","article-title":"Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens","volume":"78","author":"Cappelletti M","year":"2016","unstructured":"Cappelletti M, Wallen K. Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens. Horm Behav. 2016, 78:178-193. 10.1016\/j.yhbeh.2015.11.003","journal-title":"Horm Behav"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2015.002","article-title":"Choosing a combined oral contraceptive pill","volume":"38","author":"Stewart M","year":"2015","unstructured":"Stewart M, Black K. Choosing a combined oral contraceptive pill. Aust Prescr. 2015, 38:6-11. 10.18773\/austprescr.2015.002","journal-title":"Aust Prescr"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1572546","article-title":"The current status of oral contraceptives: progress and recent innovations","volume":"34","author":"Golobof A","year":"2016","unstructured":"Golobof A, Kiley J. The current status of oral contraceptives: progress and recent innovations. Semin Reprod Med. 2016, 34:145-151. 10.1055\/s-0036-1572546","journal-title":"Semin Reprod Med"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2019.08.005","article-title":"Hormonal contraception and female sexuality: position statements from the European Society of Sexual Medicine (ESSM)","volume":"16","author":"Both S","year":"2019","unstructured":"Both S, Lew-Starowicz M, Luria M, et al.. Hormonal contraception and female sexuality: position statements from the European Society of Sexual Medicine (ESSM). J Sex Med. 2019, 16:1681-1695. 10.1016\/j.jsxm.2019.08.005","journal-title":"J Sex Med"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-018-0602-4","article-title":"Predictors of female sexual dysfunction: a systematic review and qualitative analysis through gender inequality paradigms","volume":"18","author":"McCool-Myers M","year":"2018","unstructured":"McCool-Myers M, Theurich M, Zuelke A, Knuettel H, Apfelbacher C. Predictors of female sexual dysfunction: a systematic review and qualitative analysis through gender inequality paradigms. BMC Womens Health. 2018, 18:108. 10.1186\/s12905-018-0602-4","journal-title":"BMC Womens Health"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030810","article-title":"How does contraceptive use affect women's sexuality? A novel look at sexual acceptability","volume":"11","author":"Caruso S","year":"2022","unstructured":"Caruso S, Palermo G, Caruso G, Rapisarda AM. How does contraceptive use affect women's sexuality? A novel look at sexual acceptability. J Clin Med. 2022, 11:810. 10.3390\/jcm11030810","journal-title":"J Clin Med"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9701384","article-title":"The Potential of Hormonal Contraception to Influence Female Sexuality","volume":"2019","author":"de Castro Coelho F","year":"2019","unstructured":"de Castro Coelho F, Barros C. The Potential of Hormonal Contraception to Influence Female Sexuality. Int J Reprod Med. 2019, 2019:9701384. 10.1155\/2019\/9701384","journal-title":"Int J Reprod Med"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2016.1217324","article-title":"The effect of a drospirenone-containing combined oral contraceptive on female sexual function: a prospective randomised study","volume":"21","author":"\u010ciaplinskien\u0117 L","year":"2016","unstructured":"\u010ciaplinskien\u0117 L, \u017dilaitien\u0117 B, Verkauskien\u0117 R, \u017dalinkevi\u010dius R, Bumbulien\u0117 \u017d, Vanagien\u0117 V, Bitzer J. The effect of a drospirenone-containing combined oral contraceptive on female sexual function: a prospective randomised study. Eur J Contracept Reprod Health Care. 2016, 21:395-400. 10.1080\/13625187.2016.1217324","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2020.100213","article-title":"Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle","volume":"12","author":"Hantsoo L","year":"2020","unstructured":"Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiol Stress. 2020, 12:100213. 10.1016\/j.ynstr.2020.100213","journal-title":"Neurobiol Stress"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.12703\/r\/11-11","article-title":"Recent advances in understanding\/management of premenstrual dysphoric disorder\/premenstrual syndrome","volume":"11","author":"Tiranini L","year":"2022","unstructured":"Tiranini L, Nappi RE. Recent advances in understanding\/management of premenstrual dysphoric disorder\/premenstrual syndrome. Fac Rev. 2022, 11:11. 10.12703\/r\/11-11","journal-title":"Fac Rev"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040520","article-title":"Progesterone and its metabolites play a beneficial role in affect regulation in the female brain","volume":"16","author":"Stefaniak M","year":"2023","unstructured":"Stefaniak M, Dmoch-Gajzlerska E, Jankowska K, Rogowski A, Kajdy A, Maksym RB. Progesterone and its metabolites play a beneficial role in affect regulation in the female brain. Pharmaceuticals (Basel). 2023, 16:520. 10.3390\/ph16040520","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.2147\/OAJC.S97013","article-title":"Contraceptive options for women with premenstrual dysphoric disorder: current insights and a narrative review","volume":"7","author":"Lete I","year":"2016","unstructured":"Lete I, Lapuente O. Contraceptive options for women with premenstrual dysphoric disorder: current insights and a narrative review. Open Access J Contracept. 2016, 7:117-125. 10.2147\/OAJC.S97013","journal-title":"Open Access J Contracept"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.704488","article-title":"Pilot data on the feasibility and clinical outcomes of a nomegestrol acetate oral contraceptive pill in women with premenstrual dysphoric disorder","volume":"12","author":"Robertson E","year":"2021","unstructured":"Robertson E, Thew C, Thomas N, Karimi L, Kulkarni J. Pilot data on the feasibility and clinical outcomes of a nomegestrol acetate oral contraceptive pill in women with premenstrual dysphoric disorder. Front Endocrinol (Lausanne). 2021, 12:704488. 10.3389\/fendo.2021.704488","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.2147\/ijwh.s4338","article-title":"Safety, efficacy, actions, and patient acceptability of drospirenone\/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder","volume":"1","author":"Breech LL","year":"2010","unstructured":"Breech LL, Braverman PK. Safety, efficacy, actions, and patient acceptability of drospirenone\/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder. Int J Womens Health. 2010, 1:85-95. 10.2147\/ijwh.s4338","journal-title":"Int J Womens Health"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1177\/0024363920982709","article-title":"Hormonally active contraceptives part I: risks acknowledged and unacknowledged","volume":"88","author":"Williams WV","year":"2021","unstructured":"Williams WV, Brind J, Haynes L, et al.. Hormonally active contraceptives part I: risks acknowledged and unacknowledged. Linacre Q. 2021, 88:126-148. 10.1177\/0024363920982709","journal-title":"Linacre Q"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/s0010-7824(00)00122-0","article-title":"Depressive symptoms in users and non-users of depot medroxyprogesterone acetate","volume":"61","author":"Civic D","year":"2000","unstructured":"Civic D, Scholes D, Ichikawa L, et al.. Depressive symptoms in users and non-users of depot medroxyprogesterone acetate. Contraception. 2000, 61:385-390. 10.1016\/s0010-7824(00)00122-0","journal-title":"Contraception"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp18X699473","article-title":"Hormonal contraception and suicide: a new dimension of risk","volume":"68","author":"Hughes LD","year":"2018","unstructured":"Hughes LD, Majekodunmi O. Hormonal contraception and suicide: a new dimension of risk. Br J Gen Pract. 2018, 68:512-513. 10.3399\/bjgp18X699473","journal-title":"Br J Gen Pract"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2016.1217327","article-title":"Combined hormonal contraception and its effects on mood: a critical review","volume":"21","author":"Schaffir J","year":"2016","unstructured":"Schaffir J, Worly BL, Gur TL. Combined hormonal contraception and its effects on mood: a critical review. Eur J Contracept Reprod Health Care. 2016, 21:347-355. 10.1080\/13625187.2016.1217327","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1186\/s40834-022-00204-w","article-title":"Psychological side effects of hormonal contraception: a disconnect between patients and providers","volume":"8","author":"Martell S","year":"2023","unstructured":"Martell S, Marini C, Kondas CA, Deutch AB. Psychological side effects of hormonal contraception: a disconnect between patients and providers. Contracept Reprod Med. 2023, 8:9. 10.1186\/s40834-022-00204-w","journal-title":"Contracept Reprod Med"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0683-x","article-title":"Cohort study of psychiatric adverse events following exposure to levonorgestrel-containing intrauterine devices in UK general practice","volume":"41","author":"Slattery J","year":"2018","unstructured":"Slattery J, Morales D, Pinheiro L, Kurz X. Cohort study of psychiatric adverse events following exposure to levonorgestrel-containing intrauterine devices in UK general practice. Drug Saf. 2018, 41:951-958. 10.1007\/s40264-018-0683-x","journal-title":"Drug Saf"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2022.025","article-title":"Hormonal contraception and mood disorders","volume":"45","author":"Mu E","year":"2022","unstructured":"Mu E, Kulkarni J. Hormonal contraception and mood disorders. Aust Prescr. 2022, 45:75-79. 10.18773\/austprescr.2022.025","journal-title":"Aust Prescr"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2020-200658","article-title":"Towards individualised contraceptive counselling: clinical and reproductive factors associated with self-reported hormonal contraceptive-induced adverse mood symptoms","volume":"47","author":"Lundin C","year":"2021","unstructured":"Lundin C, Wikman A, Bixo M, Gemzell-Danielsson K, Sundstr\u00f6m Poromaa I. Towards individualised contraceptive counselling: clinical and reproductive factors associated with self-reported hormonal contraceptive-induced adverse mood symptoms. BMJ Sex Reprod Health. 2021, 47:e8. 10.1136\/bmjsrh-2020-200658","journal-title":"BMJ Sex Reprod Health"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796023000525","article-title":"Population-based cohort study of oral contraceptive use and risk of depression","volume":"32","author":"Johansson T","year":"2023","unstructured":"Johansson T, Vinther Larsen S, Bui M, Ek WE, Karlsson T, Johansson \u00c5. Population-based cohort study of oral contraceptive use and risk of depression. Epidemiol Psychiatr Sci. 2023, 32:e39. 10.1017\/S2045796023000525","journal-title":"Epidemiol Psychiatr Sci"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262130-00004","article-title":"Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?","volume":"62","author":"Pearlstein T","year":"2002","unstructured":"Pearlstein T. Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?. Drugs. 2002, 62:1869-1885. 10.2165\/00003495-200262130-00004","journal-title":"Drugs"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19ac13071","article-title":"Evidence-based treatment of premenstrual dysphoric disorder: a concise review","volume":"81","author":"Carlini SV","year":"2020","unstructured":"Carlini SV, Deligiannidis KM. Evidence-based treatment of premenstrual dysphoric disorder: a concise review. J Clin Psychiatry. 2020, 81:10.4088\/JCP.19ac13071","journal-title":"J Clin Psychiatry"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2020.100856","article-title":"Progesterone - Friend or foe?","volume":"59","author":"Sundstr\u00f6m-Poromaa I","year":"2020","unstructured":"Sundstr\u00f6m-Poromaa I, Comasco E, Sumner R, Luders E. Progesterone - Friend or foe?. Front Neuroendocrinol. 2020, 59:100856. 10.1016\/j.yfrne.2020.100856","journal-title":"Front Neuroendocrinol"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1177\/02698811221099645","article-title":"Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: a systematic review and meta-analysis of randomised trials","volume":"37","author":"Reilly TJ","year":"2023","unstructured":"Reilly TJ, Wallman P, Clark I, Knox CL, Craig MC, Taylor D. Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: a systematic review and meta-analysis of randomised trials. J Psychopharmacol. 2023, 37:261-267. 10.1177\/02698811221099645","journal-title":"J Psychopharmacol"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2014.00137","article-title":"A comparative qualitative study of misconceptions associated with contraceptive use in southern and northern ghana","volume":"2","author":"Adongo PB","year":"2014","unstructured":"Adongo PB, Tabong PT, Azongo TB, Phillips JF, Sheff MC, Stone AE, Tapsoba P. A comparative qualitative study of misconceptions associated with contraceptive use in southern and northern ghana. Front Public Health. 2014, 2:137. 10.3389\/fpubh.2014.00137","journal-title":"Front Public Health"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1016\/j.conx.2021.100062","article-title":"Stigma surrounding contraceptive use and abortion among secondary school teachers: A cross-sectional study in Western Kenya","volume":"3","author":"Meurice ME","year":"2021","unstructured":"Meurice ME, Otieno B, Chang JJ, Makenzius M. Stigma surrounding contraceptive use and abortion among secondary school teachers: A cross-sectional study in Western Kenya. Contracept X. 2021, 3:100062. 10.1016\/j.conx.2021.100062","journal-title":"Contracept X"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.13946","article-title":"Reasons women do not seek health care for dysmenorrhea","volume":"27","author":"Chen CX","year":"2018","unstructured":"Chen CX, Shieh C, Draucker CB, Carpenter JS. Reasons women do not seek health care for dysmenorrhea. J Clin Nurs. 2018, 27:e301-e308. 10.1111\/jocn.13946","journal-title":"J Clin Nurs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/254199-understanding-the-interplay-between-premenstrual-dysphoric-disorder-pmdd-and-female-sexual-dysfunction-fsd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T02:02:34Z","timestamp":1718935354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/254199-understanding-the-interplay-between-premenstrual-dysphoric-disorder-pmdd-and-female-sexual-dysfunction-fsd"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":112,"URL":"https:\/\/doi.org\/10.7759\/cureus.62788","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,20]]}}}